KEGG   PATHWAY: phas04650
Entry
phas04650                   Pathway                                
Name
Natural killer cell mediated cytotoxicity - Phyllostomus hastatus (greater spear-nosed bat)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
phas04650  Natural killer cell mediated cytotoxicity
phas04650

Other DBs
GO: 0042267
Organism
Phyllostomus hastatus (greater spear-nosed bat) [GN:phas]
Gene
123804403  VAV3; guanine nucleotide exchange factor VAV3 isoform X1 [KO:K05730]
123804414  NRAS; GTPase NRas [KO:K07828]
123804815  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
123805534  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
123805718  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
123806496  LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356]
123806569  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
123806766  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
123807317  HRAS; GTPase HRas isoform X1 [KO:K02833]
123807416  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
123807983  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
123808110  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
123808561  LCP2; lymphocyte cytosolic protein 2 isoform X1 [KO:K07361]
123808639  SHC4; SHC-transforming protein 4 [KO:K17449]
123810428  NCR3; natural cytotoxicity triggering receptor 3 isoform X1 [KO:K06743]
123810433  TNF; tumor necrosis factor isoform X1 [KO:K03156]
123810462  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
123810706  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
123811120  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
123811378  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
123811734  [KO:K07360] [EC:2.7.10.2]
123811909  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
123812406  KRAS; GTPase KRas isoform X1 [KO:K07827]
123812973  IFNG; interferon gamma [KO:K04687]
123813399  [KO:K06741]
123813640  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
123813838  SHC2; SHC-transforming protein 2 [KO:K17447]
123814030  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
123814146  VAV1; proto-oncogene vav isoform X1 [KO:K05730]
123814364  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
123814793  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
123815210  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
123815559  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
123815569  SHC3; SHC-transforming protein 3 isoform X1 [KO:K17448]
123815917  SH3BP2; LOW QUALITY PROTEIN: SH3 domain-binding protein 2 [KO:K07984]
123816243  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
123817218  ICAM2; intercellular adhesion molecule 2 isoform X1 [KO:K06523]
123817350  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
123817374  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
123817558  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
123817896  [KO:K06541]
123818273  FCGR3A; low affinity immunoglobulin gamma Fc region receptor III-A [KO:K06463]
123818339  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
123818449  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
123818494  CD244; natural killer cell receptor 2B4 [KO:K06582]
123818553  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
123818568  CD247; T-cell surface glycoprotein CD3 zeta chain [KO:K06453]
123818775  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
123819053  [KO:K04726]
123819368  [KO:K06541]
123819372  [KO:K06541]
123819375  [KO:K06541]
123819376  [KO:K06541]
123819381  [KO:K06541]
123819382  [KO:K06728]
123819384  [KO:K06541]
123819385  [KO:K06728]
123819388  [KO:K06541]
123819390  [KO:K06516]
123819393  [KO:K06541]
123819394  [KO:K06541]
123819395  [KO:K06541]
123819404  [KO:K06541]
123819423  [KO:K06516]
123819865  [KO:K05414]
123819961  [KO:K05414]
123819962  [KO:K05414]
123820149  [KO:K05415]
123820198  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
123820232  IFNB1; interferon beta [KO:K05415]
123820366  [KO:K06541]
123820369  [KO:K06541]
123820370  [KO:K06541]
123820443  [KO:K01353] [EC:3.4.21.79]
123820457  [KO:K01353] [EC:3.4.21.79]
123820630  CD48; CD48 antigen [KO:K06479]
123820880  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
123820944  PRF1; perforin-1 [KO:K07818]
123820995  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
123821442  NCR2; LOW QUALITY PROTEIN: natural cytotoxicity triggering receptor 2 [KO:K06742]
123821592  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
123821787  [KO:K07987]
123821789  [KO:K07987]
123821790  IFNGR1; interferon gamma receptor 1 [KO:K05132]
123821876  [KO:K07987]
123821877  [KO:K07986]
123821939  [KO:K07986]
123821972  RAET1E; retinoic acid early transcript 1E isoform X1 [KO:K07987]
123822058  [KO:K07986]
123823384  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
123823829  [KO:K07992]
123823873  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
123824140  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
123824527  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
123825494  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
123825523  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
123825537  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
123825544  LAT; linker for activation of T-cells family member 1 isoform X1 [KO:K07362]
123825630  [KO:K04409] [EC:2.7.11.1]
123826011  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
123826750  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
123827114  TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721]
123827727  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
123827887  [KO:K06541]
123827993  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
123828042  IFNGR2; interferon gamma receptor 2 [KO:K05133]
123828062  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
123828067  ITGB2; integrin beta-2 [KO:K06464]
123828197  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
123828291  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
123828317  [KO:K04722]
123828517  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
123829139  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
123829653  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
123830565  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
123831922  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
123832115  LCK; tyrosine-protein kinase Lck isoform X1 [KO:K05856] [EC:2.7.10.2]
123832298  [KO:K02649]
123832643  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
phas04010  MAPK signaling pathway
phas04020  Calcium signaling pathway
phas04060  Cytokine-cytokine receptor interaction
phas04210  Apoptosis
phas04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system